Premium Financials Agenda

Faça Login ou Cadastre-se para ter acesso completo.

Supercharge your analysis with exclusive data on more than 6000 companies.

All your companies centralized on a single place.

A powerful Screener with all companies and indicators available on the site.

All the companies you've bookmarked to learn more.

Compare up to 5 companies, using more than 900 exclusive indicators between Stocks, REITs, Ações and FIIs.

Review and analyze updated financials of more than 6.000 Stocks, REITs, FIIs and Ações.

See the most complete corporate Events Calendar in the world.

Don't miss anything regarding the companies that matter most. Join our discussions.

All material facts published in the last 90 days.

Get ahead with the best companies ranked by the community.

Price • Legend Biotech

LEGN

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Historical stock price chart and annual return over the past years

LL

15%

5 years

% Total

LEGN

3%

5 years

Annual Return

LEGN